Meeting
2023 ASCO Genitourinary Cancers Symposium
Clinical and immunogenomic outcomes of consolidative cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint blockade.
Authors
Stephen W. Reese
Memorial Sloan Kettering Cancer Center, New York City, NY
Stephen W. Reese , Hui Jiang , Fengshen Kuo , Chih-Ying Wu , Lynda Vuong , Eduardo Mascareno , Arnold Oparanozie , Robert J. Motzer , Martin H Voss , Eduard Reznik , Victor E. Reuter , Jonathan Coleman , Paul Russo , Ying-Bei Chen , Ritesh R Kotecha , A. Ari Hakimi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 720)
DOI
10.1200/JCO.2023.41.6_suppl.720
Abstract #
720
Poster Bd #
K15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Linear muscle segmentation for metastatic renal cell carcinoma.
First Author: Edouard Nicaise
Poster
2016 Genitourinary Cancers Symposium
Time to targeted therapy after cytoreductive nephrectomy (CN) and surveillance in patients with synchronous unresectable metastases of renal cell carcinoma (RCC).
First Author: Axel Bex
First Author: Julie A. Cupp
Poster
2024 ASCO Annual Meeting
NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).
First Author: William A. Hall